DocGo Inc. Asset Acquisition Consideration Transferred Transaction Cost
DocGo Inc. (DCGO) reported Asset Acquisition Consideration Transferred Transaction Cost of $9.60 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost · last filed 2024-11-07
- DocGo Inc. asset acquisition consideration transferred transaction cost for the quarter ending 2022-09-30 was $0.00.
| Period end | Asset Acquisition Consideration Transferred Transaction Cost | Asset Acquisition Consideration Transferred Transaction Cost 3 month | Asset Acquisition Consideration Transferred Transaction Cost 6 month | Asset Acquisition Consideration Transferred Transaction Cost 9 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $9.60M 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $9.60M 10-Q · filed 2022-08-09 | |||
| 2021-11-05 | $114.60M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |